Ekso Bionics Holdings, Inc. (EKSO) Financial Statements & Historical Data

Ekso Bionics Holdings, Inc. (EKSO) — Price $15.90 TechnologyInformation Technology Services — NASDAQ

Latest reported results:

Detailed financial statements for Ekso Bionics Holdings, Inc. (EKSO): income statement, balance sheet and cash-flow summary. Track margins, debt, liquidity and profitability trends year over year with up to 20 years of history.

Ekso Bionics Holdings, Inc. designs, develops, distributes, and commercializes exoskeleton products in the Americas, Europe, the Middle East, Africa, the Asia Pacific, and internationally. The company provides EksoNR, a wearable robotic exoskeleton; Ekso Indego Therapy, a powered exoskeleton; Ekso Indego Personal, a powered lower limb orthosis; and Ekso EVO, a wearable upper body exoskeleton.

Analysis Summary

Ekso Bionics Holdings, Inc. reported revenue of $12.8M in the most recent fiscal year, growing at a 5-year CAGR of 7.6%.

Trailing-twelve-month margins: gross margin 52.9%, operating margin -134.1%, net margin -135.7%.

At the current price of $15.90, EKSO has negative trailing earnings (P/E not meaningful) and an ROE of -177.40%. Market capitalisation stands at $39M.

Balance sheet quality for EKSO: current ratio of 1.6, net debt of $3.5M. A debt-to-equity below 1.0 typically signals conservative capital structure, while a current ratio above 1.5 indicates comfortable short-term liquidity.

Income Statement (10y)

Year2016201720182019202020212022202320242025
Revenue$14.2M$7.4M$11.3M$13.9M$8.9M$11.2M$12.9M$18.3M$17.9M$12.8M
Cost of Revenue$11.3M$5.3M$7.0M$7.2M$3.8M$4.5M$6.7M$9.2M$8.4M$6.0M
Gross Profit$2.9M$2.1M$4.3M$6.8M$5.1M$6.7M$6.2M$9.1M$9.5M$6.8M
Research & Development$8.9M$9.5M$5.8M$4.6M$2.5M$2.7M$3.6M$5.0M$3.9M$3.0M
Selling, General & Admin$21.9M$23.9M$25.5M$18.8M$15.5M$17.8M$18.1M$19.2M$16.1M$17.1M
Operating Expenses$30.7M$33.4M$31.4M$23.4M$17.9M$20.6M$21.8M$24.2M$20.0M$20.2M
Operating Income-$27.6M-$31.6M-$27.0M-$16.6M-$12.9M-$13.8M-$15.6M-$15.1M-$10.5M-$13.3M
EBITDA-$21.6M-$26.7M-$24.9M-$11.1M-$15.1M-$9.1M-$14.0M-$13.2M-$9.5M-$9.8M
Interest Expense$16000$648000$600000$384000$139000$113000$156000$302000$269000$309000
Pre-tax Income-$23.5M-$29.1M-$27.0M-$12.1M-$15.8M-$9.8M-$15.1M-$15.2M-$11.3M-$11.7M
Income Tax0000000000
Net Income-$23.5M-$29.1M-$27.0M-$12.1M-$15.8M-$9.8M-$15.1M-$15.2M-$11.3M-$11.7M
EPS$-419.75$-184.01$-99.19$-37.96$-33.13$-12.01$-17.45$-16.44$-8.43$-4.91
EPS (Diluted)$-419.75$-184.01$-99.19$-37.96$-33.13$-13.20$-17.45$-16.44$-8.43$-4.91
Shares Outstanding (Diluted)$80559$158262$272128$319604$477599$817933$864133$924466$1.3M$2.4M

Income Statement (Quarterly)

Year2025-Q22025-Q32025-Q42026-Q1
Revenue$2.1M$4.2M$3.1M$2.1M
Gross Profit$819000$2.5M$1.7M$1.1M
Operating Income-$4.0M-$1.4M-$4.5M-$5.6M
EBITDA-$2.3M-$1.0M-$3.8M-$6.3M
Net Income-$2.7M-$1.4M-$4.7M-$6.9M
EPS$-1.24$-0.54$-1.57$-2.04
EPS (Diluted)$-1.24$-0.54$-1.57$-2.04

Balance Sheet (10y)

Year2016201720182019202020212022202320242025
Cash & Equivalents$16.8M$27.8M$7.7M$10.9M$12.9M$40.4M$20.5M$8.6M$6.5M$1.2M
Short-term Investments0000000000
Receivables$1.8M$2.8M$3.7M$5.2M$3.4M$4.7M$4.6M$5.6M$7.2M$7.3M
Inventory$1.6M$3.0M$3.4M$2.5M$2.0M$2.2M$5.2M$5.0M$4.6M$4.8M
Total Current Assets$20.7M$34.9M$15.0M$18.8M$18.4M$47.8M$31.0M$20.2M$18.8M$14.0M
Property, Plant & Equipment$2.4M$2.2M$2.4M$2.7M$1.9M$1.2M$4.0M$3.0M$2.4M$1.8M
Goodwill$189000$189000$189000$18900000$431000$431000$431000$431000
Intangible Assets$1.0M$4910000000$5.2M$4.9M$4.6M$3.5M
Total Assets$24.4M$38.0M$17.7M$21.9M$20.6M$49.2M$40.9M$28.9M$26.7M$20.1M
Accounts Payable$1.9M$2.4M$3.2M$1.9M$1.5M$3.1M$3.2M$1.8M$1.6M$1.4M
Short-term Debt0$2.1M$2.3M$2.8M$548000$229000$2.3M$1.2M$1.2M$3.3M
Total Current Liabilities$6.3M$9.2M$10.1M$7.8M$5.0M$6.9M$9.2M$8.1M$7.5M$8.6M
Long-term Debt$6.8M$4.8M$2.6M$407000$3.1M$2.0M$3.8M$4.8M$3.9M$798000
Total Liabilities$17.9M$16.6M$14.9M$15.1M$16.2M$11.9M$15.5M$16.3M$13.9M$11.1M
Retained Earnings-$114.9M-$144.2M-$171.1M-$183.3M-$199.1M-$208.9M-$223.9M-$239.1M-$250.5M-$262.4M
Total Equity$6.5M$21.4M$2.7M$6.8M$4.4M$37.2M$25.4M$12.6M$12.7M$9.0M
Total Debt$6.8M$7.0M$5.0M$3.9M$3.9M$2.2M$7.5M$7.2M$6.0M$4.6M
Net Debt-$10.0M-$20.8M-$2.7M-$7.0M-$9.0M-$38.2M-$13.0M-$1.5M-$510000$3.5M
Working Capital$14.4M$25.8M$4.8M$11.0M$13.4M$40.9M$21.8M$12.1M$11.3M$5.4M

Balance Sheet (Quarterly)

Year2025-Q22025-Q32025-Q42026-Q1
Cash & Equivalents$5.2M$2.7M$1.2M$4.0M
Total Assets$23.2M$21.7M$20.1M$19.7M
Total Liabilities$12.2M$12.0M$11.1M$13.9M
Total Equity$10.9M$9.7M$9.0M$5.7M
Total Debt$5.4M$5.0M$4.6M$4.3M

Cash Flow (10y)

Year2016201720182019202020212022202320242025
Net Income-$23.5M-$29.1M-$27.0M-$12.1M-$15.8M-$9.8M-$15.1M-$15.2M-$11.3M-$11.7M
Depreciation & Amortization$1.9M$1.7M$1.5M$690000$620000$561000$887000$1.7M$1.6M$1.6M
Stock-based Compensation$3.1M$2.9M$3.1M$2.4M$2.6M$2.5M$2.7M$2.2M$1.6M$1.5M
Change in Working Capital-$2.1M-$3.6M$530000-$2.0M$1.1M-$468000-$2.6M-$583000-$2.5M-$2.0M
Operating Cash Flow-$25.0M-$31.2M-$22.2M-$15.8M-$8.8M-$11.2M-$14.7M-$12.1M-$9.8M-$11.8M
Capital Expenditure-$1.1M-$456000-$131000-$600000-$59000-$194000-$157000-$37000-$188000
Acquisitions000000-$5.0M000
Stock Repurchased0000000000
Dividends Paid-$10.3M00000000-$226000
Free Cash Flow-$26.1M-$31.7M-$22.3M-$15.8M-$8.8M-$11.2M-$14.9M-$12.2M-$9.9M-$12.0M

Cash Flow (Quarterly)

Year2025-Q22025-Q32025-Q42026-Q1
Operating Cash Flow-$3.4M-$2.1M-$4.3M-$2.1M
Capital Expenditure-$40000$50000-$500000
Free Cash Flow-$3.5M-$2.0M-$4.4M-$2.1M
Dividends Paid0000
Stock-based Compensation$207000$259000$758000$114000

Growth & Margins (10y)

Year2016201720182019202020212022202320242025
Revenue Growth (YoY)-48.3%+54.1%+22.8%-36.2%+26.6%+14.8%+41.6%-1.9%-28.6%
Net Income Growth (YoY)-24.1%+7.3%+55.1%-30.4%+38.3%-54.4%-0.8%+25.5%-3.2%
EPS Growth (YoY)+56.2%+46.1%+61.7%+12.7%+63.7%-45.3%+5.8%+48.7%+41.8%
Shares Change (YoY)+96.5%+71.9%+17.4%+49.4%+71.3%+5.6%+7.0%+45.4%+80.5%
FCF Growth (YoY)-21.4%+29.6%+29.0%+44.7%-28.1%-32.7%+17.9%+19.1%-21.3%
Gross Margin20.7%28.1%38.0%48.6%57.1%60.0%48.1%49.7%53.1%53.5%
Operating Margin-194.0%-429.9%-238.5%-119.6%-144.8%-123.0%-120.5%-82.7%-58.4%-104.1%
EBITDA Margin-151.9%-363.7%-219.7%-79.5%-169.6%-80.8%-108.7%-72.2%-52.7%-76.7%
Net Margin-165.0%-396.1%-238.2%-87.2%-178.2%-86.8%-116.8%-83.1%-63.2%-91.4%
FCF Margin-183.5%-430.9%-196.8%-113.8%-98.6%-99.7%-115.3%-66.8%-55.1%-93.7%
Effective Tax Rate-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%-0.0%

Per-Share Data (10y)

Year2016201720182019202020212022202320242025
FCF Per Share$-323.90$-200.19$-81.93$-49.54$-18.33$-13.71$-17.22$-13.21$-7.35$-4.94
Dividends Per Share$128.42$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.09
Shares Outstanding (Basic)$80559$158262$272128$319604$477599$812866$864133$924466$1.3M$2.4M

What to look at in Technology companies

Profitability

Return on Equity-177.40%
Return on Invested Capital-108.78%
Return on Assets-79.77%
Gross Margin52.86%
Operating Margin-134.06%
Net Margin-135.66%

Financial Health

Debt / Equity0.75
Current Ratio1.55

Key Ratios (10y)

Year2016201720182019202020212022202320242025
P/E-2.13-2.60-2.81-2.32-2.78-3.31-1.02-2.28-1.09-1.76
P/B11.053.5527.834.149.900.870.612.750.972.32
P/S5.0710.326.702.024.942.871.191.900.691.64
Gross Margin20.7%28.1%38.0%48.6%57.1%60.0%48.1%49.7%53.1%53.5%
Operating Margin-194.0%-429.9%-238.5%-119.6%-144.8%-123.0%-120.5%-82.7%-58.4%-104.1%
Net Margin-165.0%-396.1%-238.2%-87.2%-178.2%-86.8%-116.8%-83.1%-63.2%-91.4%

Related companies: AEMD · ALUR · ANL · AYTU · CODX · ERNA · GOVX

Explore sector: Technology · Information Technology Services

More sections of EKSO: Overview · Valuation · Statistics · Estimates · Technical · Ownership · News · Events

Discover more: Radar — undervalued stock signals · Investment Academy — learn to analyze stocks